Instantaneous healthcare backed by 5G to drive the Non-Melanoma Skin Cancer Market at a CAGR of 5.9%

Non-melanoma skin cancer (NMSC) is one of the most common types of skin cancer, which usually occurs in people who have had prolonged exposure to the sun. It includes two types of skin cancer - basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). NMSC is not usually life-threatening, but it can cause significant morbidity and may require extensive surgical intervention, especially in advanced cases. The NMSC market has witnessed significant growth in recent years, owing to the increasing incidence of skin cancer, rising awareness regarding skin cancer, and the availability of new treatment options.

Market Overview:

Radiation therapy has a market share approaching 90% in the non-melanoma skin cancer treatment market in 2017 itself and is unlikely to cede this commanding position anytime soon. Radiation therapy has a value of approx. US$ 4.8 Bn by end 2025 making it considerably larger than both chemotherapy and photodynamic therapy. Within radiation therapy, external beam radiation therapy is currently the largest in terms of market value.

However, the highest CAGR of 9.6% for the period 2017-2025 is anticipated to be witnessed in the superficial radiation therapy segment as this newer treatment has relatively lesser side-effects making it preferable for patient health in the long run.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/3648

Company Profiles

Admiral SA
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Eli Lilly and Company
Elekta AB
F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Novartis AG
Mylan NV
Sun Pharmaceutical Industries Ltd.
Varian Medical Systems, Inc.
Sensus Healthcare
iCAD, Inc.
Accuray, Inc.
Ion Beam Applications SA

Drivers and Restraints:

The non-melanoma skin cancer market is primarily driven by factors such as the increasing incidence of skin cancer, growing awareness about skin cancer, and the availability of new treatment options. The rise in the aging population, prolonged exposure to the sun, and the depletion of the ozone layer have resulted in an increased incidence of skin cancer worldwide. Moreover, increasing government initiatives and awareness programs to promote the early diagnosis and treatment of NMSC are also driving market growth. The emergence of new treatment options, including immunotherapy, targeted therapy, and combination therapy, has also contributed to the growth of the NMSC market.

The high cost of treatment, side effects associated with treatments, and the lack of reimbursement policies are some of the major factors that are expected to restrain the growth of the non-melanoma skin cancer market. The high cost of treatment, including surgical intervention and medications, is a major concern for patients, especially in developing countries, which could limit market growth. Additionally, the side effects associated with treatments, such as skin irritation, inflammation, and scarring, could impact patient compliance and hinder market growth. The lack of reimbursement policies for NMSC treatment in some regions could also limit market growth.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/3648

Non-Melanoma Skin Cancer Treatment Market - Taxonomy

Treatment Type

Radiation Therapy
External Beam Radiation Therapy
Electronic Brachytherapy
Superficial Radiation Therapy
Chemotherapy
Photodynamic Therapy

Region

North America
Latin America
Europe
Asia Pacific
Middle East & Africa
Indication

Basal Cell Carcinoma
Squamous Cell Carcinoma

End User

Hospitals
Ambulatory Surgical Centers
Specialty Clinics

Access Full Report@ https://www.persistencemarketresearch.com/checkout/3648

Related Reports:

Medical Oxygen Systems Market
https://www.persistencemarketresearch.com/market-research/medical-oxygen-systems-market.asp

Gamma Knife Market
https://www.persistencemarketresearch.com/market-research/gamma-knife-market.asp

Single-Lead ECG Monitors Market
https://www.persistencemarketresearch.com/market-research/single-lead-ecg-machines-market.asp

Herpes Markers Testing Market
https://www.persistencemarketresearch.com/market-research/herpes-markers-testing-market.asp

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us:

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.